Chronic Kidney Disease
Adults with CKD may not reach BP needed to reduce cardiorenal complication risk
Reaching an appropriate blood pressure target is key to lowering risks for cardiorenal complications, but many patients with chronic kidney disease may be unable to do so, prospective study data show.
National Kidney Foundation invests in health tech company Revalia Bio
The National Kidney Foundation Innovation Fund has invested in health technology company Revalia Bio, according to a press release.
CMHC to provide ‘exciting’ updates spanning cardio-kidney-metabolic sector
The 19th annual Cardiometabolic Health Congress will be held at the Boston Park Plaza and will feature the latest science in the areas of cardio-renal, obesity, diabetes and dyslipidemia, atherosclerosis, thrombosis and more.
Canagliflozin tied to improved iron, hemoglobin levels with type 2 diabetes, CKD
Canagliflozin was associated with increased iron utilization and improved hemoglobin levels for adults with type 2 diabetes and chronic kidney disease, according to data published in Nephrology Dialysis Transplantation.
Extracorporeal blood purification during cardiac surgery may help reduce post-surgical AKI
A nonselective extracorporeal blood purifier connected to the cardiopulmonary bypass circuit during nonemergent cardiac surgery may help reduce post-surgical AKI, data show.
Cancer clinical trials commonly use ‘two most inaccurate’ tests to measure kidney function
Most cancer clinical trials use inaccurate tests to evaluate kidney function when determining participant eligibility, according to results of a cross-sectional study.
Platelet count may be linked with 30-day in-hospital mortality in patients with ESKD
There may be a nonlinear connection between platelet count and 30-day in-hospital mortality in patients with end-stage kidney disease in the ICU, according to researchers.
Q&A: What to know about pregnancy for women with kidney disease
When counseling women with kidney disease about pregnancy, nephrologists and women’s health providers must emphasize intentionality.
Zetomipzomib trial in lupus nephritis paused after four patient deaths
Kezar Life Sciences has paused a phase 2b trial of zetomipzomib in active lupus nephritis after reporting four patient deaths, according to a press release from the manufacturer.
People with an eating disorder, electrolyte abnormality faced increased risk for death
Individuals with eating disorders and abnormal electrolyte levels faced an increased risk for several adverse health outcomes, including death and hospitalization, a retrospective cohort study showed.